SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTaylor Wimpey Regulatory News (TW.)

Share Price Information for Taylor Wimpey (TW.)

Share Price is delayed by 15 minutes
Get Live Data
74.80    0.00 (0.00%)
Bid:
74.00
Ask:
100.00
Spread: 26.00 (35.135%)
Market Cap: £2.60b
TW. Live PriceLast checked at - London Stock Exchange

Intraday Taylor Wimpey Share Chart

Share Buyback Programme

26 Apr 2022 15:52

RNS Number : 4189J
Taylor Wimpey PLC
26 April 2022
 

 

 

 

 

 

 

 

 

26 April 2022

Taylor Wimpey plc

Share Buyback Programme - Launch of Second Tranche

 

Taylor Wimpey plc (the "Company") announces that it has instructed Credit Suisse International ("CSI") to purchase up to £75,000,000 of the Company's shares as part of the second tranche (the "Second Tranche") of its £150,000,000 share buyback programme announced on 3 March 2022 (the "Buyback Programme"). CSI will act as principal for the simultaneous on-sale of such shares to the Company and will make its trading decisions concerning the timing of the purchases of the Company's ordinary shares independently of the Company. Purchases of the Company's shares under the Second Tranche will commence tomorrow, 27 April 2022, and end no later than 29 July 2022.

 

The purpose of the Buyback Programme is to return excess capital to the Company's shareholders and reduce the share capital of the Company, and it is expected that the implementation of the Buyback Programme will enhance earnings per share.

 

To the extent permitted by law, ordinary shares purchased under the Buyback Programme will be cancelled.

 

Any acquisitions under the Second Tranche will be carried out within certain pre-set parameters in accordance with the Company's general authority to repurchase shares as granted at the Company's 2022 Annual General Meeting, which took place earlier today, pursuant to which the maximum number of shares to be bought back by the Company may not exceed 364,892,070 ordinary shares of 1 pence each.

 

Any acquisitions will be made in accordance with the EU Market Abuse Regulation (596/2014) as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 and Chapter 12 of the Listing Rules.

 

 

-Ends-

 

 

For further information please contact:

Taylor Wimpey plc Tel: +44 (0) 1494 858323

Chris Carney, Group Finance Director

Alice Black, Group General Counsel and Company Secretary

 

Notes to editors:

Taylor Wimpey plc is a customer-focused homebuilder operating at a local level from 23 regional businesses across the UK. We also have operations in Spain. Our purpose is to deliver great homes and create thriving communities.

For further information please visit the Group's website: www.taylorwimpey.co.uk/corporate

Follow us on Twitter @TaylorWimpeyplc

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSIFMITMTATBBT
Date   Source Headline
3rd Mar 20254:33 pmRNSDirector/PDMR Shareholding
3rd Mar 20254:09 pmRNSTotal Voting Rights
28th Feb 20253:28 pmRNSDirector/PDMR Shareholding
27th Feb 20257:00 amRNSTAYLOR WIMPEY PLC FULL YEAR RESULTS
12th Feb 20252:47 pmRNSDirector/PDMR Shareholding
3rd Feb 20252:04 pmRNSTotal Voting Rights
27th Jan 20253:58 pmRNSHolding(s) in Company
16th Jan 20257:00 amRNSTrading Statement
10th Jan 202510:48 amRNSDirector/PDMR Shareholding
2nd Jan 20251:45 pmRNSBlock listing Interim Review
2nd Jan 20251:42 pmRNSBlock listing Interim Review
2nd Jan 20251:28 pmRNSTotal Voting Rights
19th Dec 20247:31 amRNSTransaction in Own Shares
13th Dec 20243:42 pmRNSDirector/PDMR Shareholding
10th Dec 20244:50 pmRNSDirector/PDMR Shareholding
4th Dec 20245:10 pmRNSDirector/PDMR Shareholding
2nd Dec 20247:00 amRNSTotal Voting Rights
29th Nov 20249:00 amRNSDirector/PDMR Shareholding
26th Nov 20243:22 pmRNSHolding(s) in Company
22nd Nov 202411:09 amRNSDirectorate Change
19th Nov 20243:32 pmRNSDirector/PDMR Shareholding
19th Nov 20243:03 pmRNSHolding(s) in Company
13th Nov 20243:32 pmRNSHolding(s) in Company
11th Nov 20242:58 pmRNSDirector/PDMR Shareholding
11th Nov 20242:39 pmRNSHolding(s) in Company
7th Nov 20247:00 amRNSTrading Statement
1st Nov 202410:08 amRNSTotal Voting Rights
9th Oct 20242:00 pmRNSDirector/PDMR Shareholding
1st Oct 20241:26 pmRNSTotal Voting Rights
26th Sep 20242:40 pmRNSDirector/PDMR Shareholding
20th Sep 202412:47 pmRNSHolding(s) in Company
10th Sep 20244:08 pmRNSDirector/PDMR Shareholding
2nd Sep 20243:30 pmRNSTotal Voting Rights
9th Aug 20242:36 pmRNSDirector/PDMR Shareholding
1st Aug 20242:57 pmRNSTotal Voting Rights
31st Jul 20247:05 amRNSBoard Committee Change
31st Jul 20247:00 amRNSHalf year results 2024
26th Jul 20243:22 pmRNSHolding(s) in Company
22nd Jul 20249:10 amRNSHolding(s) in Company
9th Jul 202411:26 amRNSDirector/PDMR Shareholding
1st Jul 20243:12 pmRNSTotal Voting Rights
1st Jul 202410:31 amRNSBlock listing Interim Review
1st Jul 202410:29 amRNSBlock listing Interim Review
17th Jun 20243:18 pmRNSDirector/PDMR Shareholding
6th Jun 202411:22 amRNSHolding(s) in Company
3rd Jun 20249:17 amRNSTotal Voting Rights
30th May 20244:07 pmRNSDirector/PDMR Shareholding
17th May 20247:15 amRNSDirector/PDMR Shareholding
15th May 20241:09 pmRNSDirector/PDMR Shareholding
9th May 202411:07 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.